{
    "organizations": [],
    "uuid": "9b4adca1c88a46f17830cf337f56a06ac1ca5bc3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-forward-pharma-says-european-paten/brief-forward-pharma-says-european-patent-office-has-revoked-ep2801355-patent-idUSFWN1PO11G",
    "ord_in_thread": 0,
    "title": "BRIEF-Forward Pharma Says ‍European Patent Office Has Revoked EP2801355 Patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 29, 2018 / 4:08 PM / in 11 minutes BRIEF-Forward Pharma Says ‍European Patent Office Has Revoked EP2801355 Patent Reuters Staff 1 Min Read \nJan 29 (Reuters) - Forward Pharma A/S: \n* FORWARD PHARMA ANNOUNCES THE DECISION OF THE EUROPEAN PATENT OFFICE IN THE OPPOSITION PROCEEDINGS FOR THE EP2801355 PATENT \n* SAYS ‍EUROPEAN PATENT OFFICE HAS REVOKED EP2801355 PATENT FOLLOWING ORAL HEARING IN OPPOSITION PROCEEDINGS​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-29T18:08:00.000+02:00",
    "crawled": "2018-01-29T18:32:20.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "pharma",
        "say",
        "patent",
        "office",
        "revoked",
        "ep2801355",
        "patent",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "forward",
        "pharma",
        "forward",
        "pharma",
        "announces",
        "decision",
        "european",
        "patent",
        "office",
        "opposition",
        "proceeding",
        "ep2801355",
        "patent",
        "say",
        "patent",
        "office",
        "revoked",
        "ep2801355",
        "patent",
        "following",
        "oral",
        "hearing",
        "opposition",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}